• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压性心脏病:它真的是一种病理学上的疾病吗?

Hypertensive heart disease: is it really a pathology?

作者信息

Bellicini Maria Giulia

机构信息

Institute of Cardiology, Spedali Civili di Brescia, Brescia, Italy.

出版信息

Hypertens Res. 2025 Aug 4. doi: 10.1038/s41440-025-02312-x.

DOI:10.1038/s41440-025-02312-x
PMID:40760163
Abstract

Hypertensive heart disease is not a direct cause of heart failure. Left ventricular hypertrophy is common in hypertension but rarely progresses to HFpEF or HFrEF. The true cardiovascular consequences of hypertension are primarily mediated by atherosclerosis and microvascular dysfunction, leading to stroke and myocardial infarction.

摘要

高血压性心脏病并非心力衰竭的直接病因。左心室肥厚在高血压患者中很常见,但很少进展为射血分数保留的心力衰竭(HFpEF)或射血分数降低的心力衰竭(HFrEF)。高血压真正的心血管后果主要由动脉粥样硬化和微血管功能障碍介导,进而导致中风和心肌梗死。

相似文献

1
Hypertensive heart disease: is it really a pathology?高血压性心脏病:它真的是一种病理学上的疾病吗?
Hypertens Res. 2025 Aug 4. doi: 10.1038/s41440-025-02312-x.
2
Safety and Efficacy of Anti-Hypertensive Medications in Patients with Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-analysis.抗高血压药物在射血分数保留的心力衰竭患者中的安全性和疗效:系统评价和荟萃分析。
High Blood Press Cardiovasc Prev. 2024 May;31(3):239-249. doi: 10.1007/s40292-024-00646-0. Epub 2024 May 13.
3
Myocardial contrast echocardiography evaluation of coronary microvascular dysfunction to Predict MACEs in patients with heart failure with preserved ejection fraction follow-up.心肌声学造影评估冠状动脉微血管功能障碍预测射血分数保留的心力衰竭患者的主要不良心血管事件的随访。
BMC Cardiovasc Disord. 2024 Sep 18;24(1):496. doi: 10.1186/s12872-024-04173-7.
4
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.用于射血分数保留的慢性心力衰竭的β受体阻滞剂和肾素-血管紧张素-醛固酮系统抑制剂。
Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD012721. doi: 10.1002/14651858.CD012721.pub2.
5
The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced ejection fraction: a systematic review.生长分化因子 15、半乳糖凝集素 3 和可溶性 ST2 作为心力衰竭保留射血分数和心力衰竭射血分数降低的诊断生物标志物的效用:系统评价。
Heart Fail Rev. 2021 Jul;26(4):799-812. doi: 10.1007/s10741-020-09913-3.
6
Coronary microvascular dysfunction and heart failure with preserved ejection fraction: what are the mechanistic links?冠状动脉微血管功能障碍与射血分数保留的心力衰竭:其机制联系是什么?
Curr Opin Cardiol. 2023 Nov 1;38(6):521-526. doi: 10.1097/HCO.0000000000001082. Epub 2023 Aug 28.
7
Systematic review and meta-analysis of stroke and thromboembolism risk in atrial fibrillation with preserved vs. reduced ejection fraction heart failure.射血分数保留与降低的心衰伴房颤患者卒中及血栓栓塞风险的系统评价和荟萃分析。
BMC Cardiovasc Disord. 2024 Sep 18;24(1):495. doi: 10.1186/s12872-024-04133-1.
8
Primary heart failure with preserved ejection fraction: The intertwined pathophysiology and treatment of some of the most relevant phenotypes.射血分数保留的原发性心力衰竭:一些最相关表型的相互交织的病理生理学与治疗
Rev Port Cardiol. 2025 Jul;44(7):445-456. doi: 10.1016/j.repc.2025.02.007. Epub 2025 Jun 3.
9
The importance of integrated left atrial evaluation: From hypertension to heart failure with preserved ejection fraction.综合左心房评估的重要性:从高血压到射血分数保留的心力衰竭。
Int J Clin Pract. 2018 Feb;72(2). doi: 10.1111/ijcp.13050. Epub 2017 Dec 28.
10
Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity: The SUMMIT Trial.慢性肾脏病与替尔泊肽对射血分数保留的肥胖心力衰竭患者的影响:SUMMIT试验
J Am Coll Cardiol. 2025 May 13;85(18):1721-1735. doi: 10.1016/j.jacc.2025.03.009. Epub 2025 Mar 31.

本文引用的文献

1
A normal heart doesn't fail: rethinking HFpEF in acute settings.正常心脏不会衰竭:重新审视急性情况下的射血分数保留的心力衰竭
Intern Emerg Med. 2025 Jun 18. doi: 10.1007/s11739-025-03989-1.
2
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).2014年欧洲心脏病学会(ESC)肥厚型心肌病诊断和治疗指南:欧洲心脏病学会(ESC)肥厚型心肌病诊断和治疗工作组
Eur Heart J. 2014 Oct 14;35(39):2733-79. doi: 10.1093/eurheartj/ehu284. Epub 2014 Aug 29.
3
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
2011年美国心脏病学会基金会/美国心脏协会肥厚型心肌病诊断和治疗指南:美国心脏病学会基金会/美国心脏协会实践指南工作组报告。与美国胸外科协会、美国超声心动图学会、美国核心脏病学会、美国心力衰竭学会、心律学会、心血管造影和介入学会以及胸外科医师学会合作制定。
J Am Coll Cardiol. 2011 Dec 13;58(25):e212-60. doi: 10.1016/j.jacc.2011.06.011. Epub 2011 Nov 8.
4
Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle.舒张性心力衰竭——左心室主动舒张和被动僵硬度异常。
N Engl J Med. 2004 May 6;350(19):1953-9. doi: 10.1056/NEJMoa032566.
5
Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.社区中收缩期和舒张期心室功能障碍的负担:认识心力衰竭流行的范围。
JAMA. 2003 Jan 8;289(2):194-202. doi: 10.1001/jama.289.2.194.
6
Impact of high-normal blood pressure on the risk of cardiovascular disease.血压略高于正常范围对心血管疾病风险的影响。
N Engl J Med. 2001 Nov 1;345(18):1291-7. doi: 10.1056/NEJMoa003417.